MedPath

Clinical research on the risk factors of Sarcopenia in diabetic patients

Not Applicable
Conditions
Diabetes, Sarcopenia, Dynapenia
Registration Number
JPRN-UMIN000020901
Lead Sponsor
Tokushima University
Brief Summary

Sarcopenia and dynapenia were more frequent in patients with type 1 diabetes and type 2 diabetes than in individuals without diabetes, which might contribute to their impaired quality of life and incidental falls.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1328
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with advanced cardiovascular, cerebrovascular and kindney disease. Patients receiving steroid treatment. Patients with gait dysfunction. Those for other reasons, who are decided as inadequate for subjects by their physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The relationship between skin autofluorescence, IGF-1, testosteron and limb skeletal muscle mass and knee extension strength(measurement of once a year).
Secondary Outcome Measures
NameTimeMethod
The relationship between sarcopenia biomarker and age and diabetes factor(measurement of once a year).
© Copyright 2025. All Rights Reserved by MedPath